MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) | MicrobiomeTrials← Back to trialsNCT07892651
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-10-18Est. Completion: 2028-10
Enrollment target: 5,000 participants Other microbiome trials you might be interested in
Antiphospholipid Syndrome (APS)
The purpose of this study is to explore if certain commensals within the gut microbiota (the collection of all microbes …
New Haven, United StatesCompleted Jan 2017
Anti Phospholipid Syndrome
AIHA is a heterogeneous autoimmune cytopenia with variable severity and significant morbidity. APS is defined by thrombo…
Al Khārjah, EgyptEst. completion Nov 30, 2027